Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?

By Dessolin J.   Schuler M.   Quinart A.   De Giorgi F.   Ghosez L.   Ichas F.  

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

Histone deacetylase inhibitors: possible implications for neurodegenerative disorders

By Hahnen Eric   Hauke Jan   Tränkle Christian   Eyüpoglu Ilker Y   Wirth Brunhilde   Blümcke Ingmar  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 169-184

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise

By  

Current Pharmaceutical Design, Vol. 15, Iss. 34, 2009-12 ,pp. : 3940-3957

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation and Absorption of Xenobiotics: The Synergistic Role of CYP450 and P-gp Activities in Cancer and Neurodegenerative Disorders

By  

Current Drug Metabolism, Vol. 12, Iss. 8, 2011-10 ,pp. : 702-712

Bentham Science Publishers

Access to resources Recommend Favorite

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3356-3373

Bentham Science Publishers

Access to resources Recommend Favorite